Sangamo Therapeutics
SGMO
#9721
Rank
โ‚น6.82 B
Marketcap
โ‚น16.47
Share price
-19.95%
Change (1 day)
-62.34%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚น9.46 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น32.87 Million. In 2024 the company made an earning of -โ‚น9.43 Billion, an increase over its 2023 earnings that were of -โ‚น11.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น9.46 Billion0.31%
2024 -โ‚น9.43 Billion-17.27%
2023 -โ‚น11.39 Billion-40.88%
2022 -โ‚น19.27 Billion9.79%
2021 -โ‚น17.55 Billion41.52%
2020 -โ‚น12.4 Billion23.17%
2019 -โ‚น10.07 Billion36.33%
2018 -โ‚น7.39 Billion36.89%
2017 -โ‚น5.4 Billion-22.32%
2016 -โ‚น6.95 Billion54.86%
2015 -โ‚น4.49 Billion75.62%
2014 -โ‚น2.56 Billion0.13%
2013 -โ‚น2.55 Billion
2011 -โ‚น3.43 Billion43.66%
2010 -โ‚น2.39 Billion28.52%
2009 -โ‚น1.86 Billion-23.55%
2008 -โ‚น2.43 Billion2.45%
2007 -โ‚น2.38 Billion19.5%
2006 -โ‚น1.99 Billion50.78%
2005 -โ‚น1.32 Billion75%
2004 -โ‚น0.76 Billion-33.25%
2003 -โ‚น1.13 Billion-62.27%
2002 -โ‚น2.99 Billion102.82%
2001 -โ‚น1.48 Billion23.21%
2000 -โ‚น1.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.486 T-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น869.60 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น155.31 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น241.83 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น937.55 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.258 T-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น83.22 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.90 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA